This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Junttila, T. T. Articles by Elenius, K. Search for Related Content PubMed PubMed Citation Articles by Junttila, T. T. Articles by Elenius, K.

Cleavable ErbB4 Isoform in Estrogen Receptor–Regulated Growth of Breast Cancer Cells

¹ Medicity Research Laboratory, Departments of ² Medical Biochemistry and Molecular Biology and ³ Anatomy, and ⁴ Turku Postgraduate School of Biomedical Sciences, University of Turku; ⁵ Department of Oncology, Turku University Hospital, Turku, Finland; ⁶ Department of Oncology, University of Helsinki, Helsinki, Finland; ⁷ Laboratory of Cancer Biology, Institute of Medical Technology, Tampere University; and ⁸ Department of Oncology, Tampere University Hospital, Tampere, Finland

Requests for reprints: Klaus Elenius, Medicity Research Laboratory, University of Turku, Tykistokatu 6 A 4th floor FIN-20520 Turku, Finland. Phone: 358-2-3337569; Fax: 358-2-3337229; E-mail: klaus.elenius{at}utu.fi.

ErbB1 and ErbB2 receptors are well-characterized targets for anticancer drugs, but the clinical relevance of the related ErbB4 receptor is unknown. Here, we have assessed the clinical significance of the proteolytically cleavable ErbB4 isoforms in breast cancer patients and investigated their functions in vitro. The expression of transcripts encoding the cleavable ErbB4 isoforms associated with estrogen receptor- (ER) expression (P < 0.001) and a high histologic grade of differentiation (P 0.002) in real-time reverse transcription-PCR analysis of 62 breast cancer samples. Despite high ErbB4 mRNA expression levels in a subset of samples, ErbB4 gene amplification was not observed. High ErbB4 protein expression levels, as assessed by immunohistochemistry, associated with a favorable outcome in ER-positive cases from a series of 458 breast cancer patients (P = 0.01), whereas no association between ErbB4 expression and survival was found among women with ER-negative cancer (P = 0.86). However, nuclear ErbB4 immunoreactivity was associated with poor survival as compared with women whose cancer had membranous ErbB4 staining (P = 0.04). In vitro, overexpression of a cleavable ErbB4 isoform in ER-positive breast cancer cells resulted in translocation of a proteolytically released intracellular ErbB4 receptor fragment into the nucleus, as well as, enhanced proliferation, anchorage-independent growth, and estrogen response element–mediated transcriptional activity. These results suggest that the association of ErbB4 expression with clinical outcome is dependent on the subcellular localization of ErbB4 and that a proteinase-cleavable ErbB4 isoform promotes growth of ER-positive breast cancer and enhances ER-mediated gene transcription.

Key Words: EGFR • HER4 • hormone-dependent cancer • neuregulins • oncogenes

This article has been cited by other articles:

				A. Naresh, A. D. Thor, S. M. Edgerton, K. C. Torkko, R. Kumar, and F. E. Jones The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis Cancer Res., August 1, 2008; 68(15): 6387 - 6395. [Abstract] [Full Text] [PDF]

				C.-P. Chuu, R.-Y. Chen, J. L. Barkinge, M. F. Ciaccio, and R. B. Jones Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective Mol. Cancer Res., June 1, 2008; 6(6): 885 - 891. [Abstract] [Full Text] [PDF]

				M. Rokavec, C. Justenhoven, W. Schroth, M. A. Istrate, S. Haas, H.-P. Fischer, C. Vollmert, T. Illig, U. Hamann, Y.-D. Ko, et al. A Novel Polymorphism in the Promoter Region of ERBB4 Is Associated with Breast and Colorectal Cancer Risk Clin. Cancer Res., December 15, 2007; 13(24): 7506 - 7514. [Abstract] [Full Text] [PDF]

				R. I. Aqeilan, V. Donati, E. Gaudio, M. S. Nicoloso, M. Sundvall, A. Korhonen, J. Lundin, J. Isola, M. Sudol, H. Joensuu, et al. Association of Wwox with ErbB4 in Breast Cancer Cancer Res., October 1, 2007; 67(19): 9330 - 9336. [Abstract] [Full Text] [PDF]

				J. Omerovic, L. Santangelo, E. M.-R. Puggioni, J. Marrocco, C. Dall'Armi, C. Palumbo, F. Belleudi, L. Di Marcotullio, L. Frati, M.-R. Torrisi, et al. The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation FASEB J, September 1, 2007; 21(11): 2849 - 2862. [Abstract] [Full Text] [PDF]

				S.-M. Feng, C. I. Sartor, D. Hunter, H. Zhou, X. Yang, L. S. Caskey, R. Dy, R. S. Muraoka-Cook, and H. S. Earp III The HER4 Cytoplasmic Domain, But Not Its C Terminus, Inhibits Mammary Cell Proliferation Mol. Endocrinol., August 1, 2007; 21(8): 1861 - 1876. [Abstract] [Full Text] [PDF]

				K. E. Strunk, C. Husted, L. C. Miraglia, M. Sandahl, W. A. Rearick, D. M. Hunter, H. S. Earp III, and R. S. Muraoka-Cook HER4 D-Box Sequences Regulate Mitotic Progression and Degradation of the Nuclear HER4 Cleavage Product s80HER4 Cancer Res., July 15, 2007; 67(14): 6582 - 6590. [Abstract] [Full Text] [PDF]

				C. C. Lynch, T. Vargo-Gogola, M. D. Martin, B. Fingleton, H. C. Crawford, and L. M. Matrisian Matrix Metalloproteinase 7 Mediates Mammary Epithelial Cell Tumorigenesis through the ErbB4 Receptor Cancer Res., July 15, 2007; 67(14): 6760 - 6767. [Abstract] [Full Text] [PDF]

				H.-G. Kang, J. M. Jenabi, J. Zhang, N. Keshelava, H. Shimada, W. A. May, T. Ng, C. P. Reynolds, T. J. Triche, and P. H.B. Sorensen E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase Cancer Res., April 1, 2007; 67(7): 3094 - 3105. [Abstract] [Full Text] [PDF]

				R. S. Muraoka-Cook, M. Sandahl, C. Husted, D. Hunter, L. Miraglia, S.-m. Feng, K. Elenius, and H. S. Earp III The Intracellular Domain of ErbB4 Induces Differentiation of Mammary Epithelial Cells Mol. Biol. Cell, September 1, 2006; 17(9): 4118 - 4129. [Abstract] [Full Text] [PDF]

				Y. Zhu, L. L. Sullivan, S. S. Nair, C. C. Williams, A. K. Pandey, L. Marrero, R. K. Vadlamudi, and F. E. Jones Coregulation of Estrogen Receptor by ERBB4/HER4 Establishes a Growth-Promoting Autocrine Signal in Breast Tumor Cells Cancer Res., August 15, 2006; 66(16): 7991 - 7998. [Abstract] [Full Text] [PDF]

				J. A. Maatta, M. Sundvall, T. T. Junttila, L. Peri, V. J. O. Laine, J. Isola, M. Egeblad, and K. Elenius Proteolytic Cleavage and Phosphorylation of a Tumor-associated ErbB4 Isoform Promote Ligand-independent Survival and Cancer Cell Growth Mol. Biol. Cell, January 1, 2006; 17(1): 67 - 79. [Abstract] [Full Text] [PDF]

				R. R. Arasada and G. Carpenter Secretase-dependent Tyrosine Phosphorylation of Mdm2 by the ErbB-4 Intracellular Domain Fragment J. Biol. Chem., September 2, 2005; 280(35): 30783 - 30787. [Abstract] [Full Text] [PDF]